[Case Study] Shogo Otake and Masashi Kasai “AMR can affect newborns! A 5-month-old boy with a urinary tract infection caused by AMR bacteria” (AMR Alliance Japan, October 12, 2021)
date : 10/12/2021
Tags: AMR
![[Case Study] Shogo Otake and Masashi Kasai “AMR can affect newborns! A 5-month-old boy with a urinary tract infection caused by AMR bacteria” (AMR Alliance Japan, October 12, 2021)](https://hgpi.org/en/wp-content/uploads/sites/2/amr-case02-top_ENG.jpg)
As part of the Alliance’s project to promote antimicrobial stewardship, AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) has begun publishing case studies from various experts related to antimicrobial resistance.
Dr. Shogo Otake and Dr. Masashi Kasai (Department of Infectious Diseases, Hyogo Prefectural Kobe Children’s Hospital) reports a case titled “AMR can affect newborns! A 5-month-old boy with a urinary tract infection caused by AMR bacteria.”
Case study 02
Dr. Shogo Otake and Dr. Masashi Kasai (Department of Infectious Diseases, Hyogo Prefectural Kobe Children’s Hospital)
“AMR can affect newborns! A 5-month-old boy with a urinary tract infection caused by AMR bacteria”
For further information, please see the case study below.
Case study 01
Dr. Keiji Okinaka (Director of Infection Control and Prevention Section, National Cancer Center Hospital East / Department of General Internal Medicine, National Cancer Center Hospital East /Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital)
“A disseminated filamentous fungal infection that broke through echinocandin antifungal treatment”
![[AMR Case Study 02] AMR can affect newborns! A 5-month-old boy with a urinary tract infection caused by AMR bacteria](/assets/img/katsudo/icon_pdf_l.png){kind=icon}
Top Research & Recommendations Posts
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Cancer Control Project “Policy Recommendations on Addressing Regional Disparities in Breast Cancer Care” (January 31, 2025)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022）
- [Discussion Points] Intractable & Rare Diseases Project Discussion Paper “Intractable & Rare Diseases 2025: 10 Years After the Passing of the Intractable Diseases Act, Toward a Co-created Future” (Mar 28, 2025)
- [Policy Recommendations] Achieving a Sustainable Society of Health and Longevity Through the Integration of Environment and Healthcare-Incorporating a Planetary Health Perspective into the 3rd Phase of The Healthcare Policy-(December 20, 2024)
- [Policy Recommendations] Dementia Project Information Packet for Local Government Officials “Dementia Policies for Our City: Taking the First Step in Promoting Future Measures for Dementia” (March 17, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Public Comment Submission] “2050 Tokyo Strategy: Making Tokyo Even Better (Draft)” (March 3, 2025)
- [Public Comment Submission] “GX2040 Vision (Draft)” (January 26, 2025)
![[Registration Open] (Webinar) The 132nd HGPI Seminar “Considering the Ideal Evidence-Based Immunization and Vaccination Policies” (April 25, 2025)](https://hgpi.org/en/wp-content/uploads/sites/2/hs132-top.png)
![[Registration Open] Public Event “The Patient and Citizen Lived Experience Forum 2025” (May 17, 2025)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20250517_PeoplewithLivedExperienceForum2025-.jpg)
